Cardiovascular disease arrhythmia

Contraindications Agitated states, glaucoma, history of drug abuse, symptomatic cardiovascular disease (arrhythmias), co-administration with or within 14 days of MAOl therapy, hypersensitivity to mazindol... 

Thyroid disorders (hypothyroidism or hyperthyroidism) Cardiovascular disease (arrhythmias, congestive heart failure) Gastrointestinal disease or disorder (sprue or other malabsorption syndromes, peptic ulcer, cohtis)... 

Other cardiovascular diseases cover a long Hst of circulatory problems, including heart faHure, peripheral vascular disease, cardiomyopathy, and arrhythmias. 

Cardiovascular Effects. Chronic cardiovascular disease has not been reported in workers occupationally exposed to low levels of trichloroethylene (El Ghawabi et al. 1973), although deaths following acute high-level inhalation exposures to trichloroethylene have been attributed to cardiac arrhythmias. Case studies have described cardiac arrhythmias that in some instances led to death after occupational exposure (Bell 1951 Kleinfeld and Tabershaw 1954 Smith 1966), poisoning (Dhuner et al. 1957 Gutch et al. 1965), or... 

Cardiovascular diseases hypertension, coronary heart disease, cardiomyopathy, left ventricular hypertrophy, and arrhythmia. 

Flecainide is a drug used for arrhythmias and is of particular use in ventricular arrhythmias and paroxysmal atrial fibrillation. Flecainide has a membrane-stabilising activity. Use of flecainide may precipitate serious arrhythmias, even in patients with no history of cardiovascular disease and with otherwise normal hearts. 

Concomitant cardiovascular disease Do not use sibutramine in patients with a history of coronary artery disease, CHF, arrhythmias, or stroke. 

Cardiovascular disease Use with caution and monitor blood pressure in patients with mild hypertension. Not recommended for patients with symptomatic cardiovascular disease, including arrhythmias. 

Cardiovascular events There have been rare reports following administration of botulinum toxin type A for other indications of adverse events involving the cardiovascular system, including arrhythmia and Ml, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. 

Use with caution in older patients with Cardiovascular disease, especially angina, arrhythmias, or CHF Parkinsonism, Essential Tremor, Hyperthyroidism, Anxiety... 

There have been reports associating the use of phenylephrine HCl 10% ophthalmic solutions with the development of serious cardiovascular reactions, including ventricular arrhythmias and myocardial infarctions. These episodes, some ending fatally, have usually occurred in patients with preexisting cardiovascular diseases. 

Noble, D. and Noble, P. J. Late sodium current in the pathophysiology of cardiovascular disease consequences of sodium-calcium overload. Heart 2006, 92 ivl-iv5. Noble, D. and Varghese, A. Modeling of sodium-calcium overload arrhythmias and... 

Herbs have been used as medical treatments since the beginning of civilization and some herbal derivatives (e.g., aspirin, reserpine, and digitalis) have become a mainstay of human pharmacotherapy. For cardiovascular diseases, herbal treatments have been used in patients with congestive heart failure, systolic hypertension, angina pectoris, atherosclerosis, cerebral insufficiency, venous insufficiency, and arrhythmia. Scientific validation of several plant species has proved the efficacy of the botanicals in reducing the... 

Cardiovascular disease is characterized by three major events (1) the formation of atherosclerotic plaques on the intima of blood vessels, which reduce the size of the lumen of the vessel (2) thrombosis or clot formation, which is the event leading directly to a coronary attack or stroke in many individuals and (3) cardiac arrhythmias, uncoordinated contractions of the heart muscle resulting in irregular and ineffective... 

Cardiovascular disease mortality, accounting for 50% of all deaths in ESRD, is defined by death caused by arrhythmias, cardiomyopathy, cardiac arrest, myocardial infarction, atherosclerotic heart disease, and pulmonary edema. Patients with ESRD should be considered in the highest risk group for subsequent cardiovascular events. Among dialysis patients, the prevalence of congestive heart failure is approximately 40%. Both coronary artery disease and LVH are risk factors for the development of heart failure. In practice, it is difficult to determine whether cardiac failure reflects left ventricular dysfunction or extracellular fluid volume overload. 

Figure 45- i 9 Cardiovascular disease mortality defined by death caused by arrhythmias, cardiomyopathy, cardiac arrest, myocardial infarction, atherosclerotic heart disease, and pulmonary edema in the general population (GP). Data from NCHS multiple cause of mortality data files compared with ESRD treated by dialysis. Data are stratified by age, race, and gender. (From Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am j Kidney Dis 1998 32 (suppi 3) SI 12-19, w/th permission from the National Kidney Foundation.)... 

---